Editor of Patient Care Online.
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.
Review of Biologic Treatments for Asthma Finds Inconsistent Effects on Airway Hyperresponsiveness
ATS 2022: Findings from a literature review provide insight into the mechanisms of airway hyperresponsiveness in asthma.
Tezepelumab Reduces Asthma Exacerbations by More than Half, Reports NAVIGATOR Study Author
Njira Lugogo, MD, sat down with Patient Care Online to discuss findings from the prespecified exploratory analysis of the NAVIGATOR study that she presented at ATS 2022.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Real-world Data Showed Mepolizumab Reduced Exacerbations, Oral Corticosteroid Use in Adults with Severe Asthma
ATS 2022: Mepolizumab was effective in reducing asthma exacerbations and oral corticosteroid use in real-world clinical practice, according to new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
NAVIGATOR Data Presented at ATS 2022 Show Improved Clinical Responses to Treatment with Tezepelumab vs Placebo
ATS 2022. A greater proportion of tezepelumab-treated patients with severe, uncontrolled asthma achieved on-treatment clinical responses than placebo-treated patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
Quality of HTN-related Videos on TikTok: Study Author Shares Findings
Lead author of a recent study sat down with Patient Care to discuss how clinicians are using the popular video sharing app and the quality of content available.
National Survey Finds Primary Care in Crisis
Primary care clinician burnout is at an all-time high and 25% of clinicians plan to leave within the next 3 years, according to a recent US survey.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
What’s Next in Brain Health? Lifestyle Interventions, Says One Expert
Henry Mahncke, PhD, explains why lifestyle interventions, such as diet and exercise, could be prescribed down the line to improve brain health.
Prototype of “Multi-tasking” Wearable Found to Continuously Monitor Glucose, Alcohol, and Lactate Levels
The wearable device allows users to monitor their health while also performing their regular daily activities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
Study: Only 3% of Adults with Overweight or Obesity in England are Referred to Weight Management Programs by Primary Care Clinician
Women, Black individuals, and adults diagnosed with overweight or obesity in more recent years were more likely to receive a referral, according to new study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
Investigational Apple Watch App Effectively Identified Left Ventricular Dysfunction using AI
New study presented at Heart Rhythm 2022 showed applying AI to an Apple Watch ECG can effectively identify LV dysfunction in a nonclinical setting.
Latest Advances in CGM Technology: A 5-question Quiz
SAMPLE: What was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?
New Findings Suggest Need for Sex-specific Strategies to Prevent Heart Attacks in Young Adults
Seven risk factors accounted for 85% of the risk of first acute myocardial infarction in young adults in a new study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
When Does Cannabis Use Become Addictive? Expert Explains How to Help Patients Navigate This Grey Area
As more states legalize cannabis for recreational purposes, it is critical for clinicians to help patients safely navigate its use.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
Study: Investigational RSV Vaccine Elicited Neutralizing Antibody Responses in Pregnant Women
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
Novel Once-Weekly Insulin Icodec Found Superior vs Insulin Degludec in Reducing HbA1c in Type 2 Diabetes
The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.
Talking Cannabis & Brain Health: Why One Expert Says Not to Condemn Use
When talking to younger cannabis users, Henry Mahncke, PhD, says it is important to first understand the underlying causes of use before counseling against it.
Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 27, 2022